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Abstract
Embryo fragmentation, or extrusion of cell fragments, is a naturally occurring phenomenon that may be associated with impaired embryo development, failed 
implantation and decreased pregnancy rates. Previous studies have shown improvement in clinical outcomes after microsurgery to aspirate these cell fragments from 
embryos early during the embryo cleavage process. This case series of three patients with infertility showcases the successful application of the defragmentation 
technique in blastocyst stage embryos after in-vitro fertilization. The timing of defragmentation allows for better identification of those growth-arrested embryos that 
would benefit from “rescue” defragmentation. All three embryos demonstrated continued expansion and development after defragmentation, and resulted in clinical 
pregnancies. 
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Introduction
Selection of the “best” embryo is a key step for single embryo 
transfer (ET) after in-vitro fertilization (IVF), which is the preferred 
technique to achieve a singleton pregnancy [1]. Embryologists select 
an embryo for transfer based on grading systems that assess the quality 
of the embryo, and predict the likelihood of successful implantation 
[2]. Grading systems, such as one reported by Gardner et al, are 
often based on three parameters: blastocoel expansion and hatching 
status, compactness and size of the inner cell mass, and the number 
and cohesiveness of trophectoderm cells, as well as state of the zona 
pellucida [2,3].  
During development, the central blastula may extrude apoptotic 
blastomeres, commonly referred to as extruded cell fragments. These 
fragments can be observed from day 2 of embryogenesis, at the start 
of the cleavage process of zygotes. This is a natural phenomenon 
commonly observed in embryo development [4,5]. It is estimated 
that about 40% of embryos demonstrate fragmentation during the 
first cleavage in-vitro [6]. Increased fragmentation, however, has been 
shown to limit subsequent blastomere development, sometimes leading 
to arrest of embryo growth [4,7]. In one study, embryos with greater 
than 15% fragmentation produced only half the number of good 
quality blastocysts, compared to the control group [8]. Further, studies 
have shown that increased embryo fragmentation is associated with 
decreased implantation [3,9,10] and pregnancy rates [5,9,11]. 
Researchers have investigated whether fragment removal can 
improve the embryonic microenvironment and facilitate embryo 
development. Evidence suggests that fragment removal improves 
embryo development [4] as well as implantation potential [9,10].  In 
recent studies, the reproductive outcomes resulting from transfer of 
defragmented embryos were either similar to [10] or better than that of 
high grade (control) embryos [5]. These studies in the literature report 
on outcomes after defragmentation of cleavage-stage embryos [6]; 
specifically, day 2 [4,5] or day 3 [9,10] embryos. This case series reports 
on the reproductive outcomes after defragmentation of blastocyst 
stage embryos after in-vitro fertilization, prior to loading embryos for 
embryo transfer. Timing the defragmentation procedure at this stage 
allowed us to identify the embryos that displayed growth arrest and 
could be successfully rescued with defragmentation.
Case presentation
Methods
Controlled ovarian hyperstimulation (COS) was performed 
with gonadotropins for 10-12 days. Follicular growth and diameter 
was monitored using serial transvaginal ultrasounds as well as 
serum estradiol. When a dominant follicle was present, final oocyte 
maturation was triggered using human chorionic gonadotropin (hCG). 
Transvaginal ultrasound guided oocyte retrieval was performed about 
35 hours after hCG administration. Collected oocytes were either 
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fragment aspiration. A day after fragment aspiration, the blastocyst 
had hatched from the zona pellucida indicating continued blastocyst 
expansion. This defragmented embryo was later transferred, and the 
patient achieved clinical pregnancy.
Case 2
The second case is a 36-year-old nulliparous female with a 5-year 
history of infertility. After an abnormal hysterosalpingograhy, she 
underwent hysteroscopic polypectomy and laparoscopic bilateral 
salpingectomy for bilateral tubal occlusion. The patient underwent 
COS, hCG trigger and oocyte aspiration, in a procedure similar to that 
of Case 1. Preimplantation genetic testing for aneuploidy (PGT-A) was 
performed after the IVF/ICSI cycle. One of two cryopreserved euploid 
embryos was thawed, and found to have multiple fragments which were 
removed. As in Case 1, there was successful embryo hatching from the 
zona pellucida after aspiration of extruded cell fragments. The patient 
underwent transfer of the defragmented embryo, and successfully 
conceived. 
Case 3
The last case is a 42-year-old G2P1011 with subclinical 
hypothyroidism who presented with infertility for one year. Evaluation 
confirmed diminished ovarian reserve. She underwent a similar 
procedure as in Cases 1 and 2, with COS, hCG trigger and oocyte 
aspiration. She declined PGT-A due to cost, and underwent fresh 
embryo transfer at the blastocyst stage in an IVF-ET cycle. This resulted 
in an early pregnancy loss. She then underwent a second IVF cycle 
with fresh embryo transfer with two defragmented blastocysts. She 
conceived and progressed to a term pregnancy. 
stripped of cumulus cells and subjected to intracytoplasmic sperm 
injection (ICSI), or were left unstripped and exposed to washed sperm 
for conventional insemination. Oocytes were assessed for fertilization 
approximately 18 hours after insemination. 
After 5 days of culture, embryos were scored using the Gardner 
grading system. Select fragmented blastocysts displaying arrest of 
growth were chosen for defragmentation.. Fragment removal was 
performed in a micromanipulation dish. The embryo was stabilized by a 
holding pipette, as seen in Figure 1, and a 1460 nm wave length infrared 
diode laser was used to create a small hole in the zona pellucida.  The 
biopsy pipette was placed inside the zona pellucida and apoptotic cell 
fragments were gently aspirated using negative pressure. The embryo 
was then returned to the culture dish and incubator. Embryos were 
reassessed the following morning to determine viability for embryo 
transfer or cryopreservation. 
The following three cases demonstrate application of this 
aspiration technique and the reproductive outcomes associated with 
defragmentation of in-vitro fertilization blastocyst stage embryos. 
Clinical characteristics of the three patients are presented in Table 1.
Case 1
The first case is a 26-year-old G2P0020 with a 2-year history of 
anovulatory infertility. She had undergone five ovulation induction 
cycles with clomiphene citrate prior to evaluation at the Reproductive 
Endocrinology and Infertility clinic. She underwent COS and oocyte 
retrieval. Most of the embryos were cryopreserved for future transfer. 
One of the embryos that demonstrated fragmentation was treated with 
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Figure 1. Photographs demonstrating an embryo before and after the defragmentation process, followed by successful development and subsequent embryo hatching. (a) Day 5 embryo 
before removal of extruded cell fragments; (b) Day 5 embryo after removal of extruded cell fragments; (c) Day 6 embryo “hatching” from zona pellucida





BMI (kg/m2) Labs Number of oocytes retrieved
Number of 
oocytes fertilized 







1 26F/30M Anovulation, tubal factor (2) 23.8
AMH 17.5 ng/mL
PRL 40.7 ng/mL
TSH 3.81 mU/L 






2 36F/36M Tubal factor (5) 23.2
AMH 8.8 ng/mL
TSH 2.13 mU/L












6 2 IVF4 cryopreserved 2, 1 Yes
Table 1. Patient clinical characteristics, results of oocyte retrieval, including number of oocytes undergoing normal fertilization (2PN) with either IVF or ICSI, number of embryos 
determined to be viable for cryopreservation, and whether pregnancy was achieved through subsequent embryo transfer
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Discussion
Embryo fragmentation has been shown to be associated with stunted 
embryo growth, poor rates of implantation and unfavorable pregnancy 
outcomes. Previous studies have examined the effect of defragmentation 
on embryo viability, during the initial cleavage process on days 2 or 3. 
We present a case series in which three patients with differing infertility 
diagnoses underwent oocyte retrieval and IVF/ICSI. Of the embryos 
achieving normal fertilization, several were found to have apoptotic cell 
fragments present at the blastocyst stage. Those embryos that displayed 
growth arrest were subjected to defragmentation. Afterwards, evidence 
of continued blastocyst expansion was observed the following day. 
Defragmented embryos displayed appropriate progression, including 
successful “hatching” from the zona pellucida. To our knowledge, this 
is the first report in which extruded, apoptotic cells were aspirated in 
a clinical setting at the blastocyst stage, with evidence of continued 
blastocyst expansion. The timing of defragmentation allows embryos to 
progress beyond the physiologic defragmentation seen during cleavage, 
and if indicated by its morphological evaluation, to undergo a “rescue” 
defragmentation process with favorable pregnancy outcomes.   
Several explanations to explain these findings have been proposed. 
Fragmentation is thought to be the result of programmed cell death, 
leading to the release of toxic substances that damage surrounding cells, 
or induce arrest of nearby blastomeres [4,9]. Further, the fragments 
may impede cell-to-cell communication by disrupting the spatial 
orientation of blastomeres or simply by crowding the space required 
for continued embryo cleavage or compaction. Some research suggests 
that fragments induce secondary degeneration in nearby structures. 
Blastomeres adjacent to extruded cell fragments have been found to 
have signs of vacuolar degeneration, seen on transmission electron 
microscopy [12,13]. With fragment removal, there is restoration 
of appropriate spatial relationship, and more adequate cell-to-cell 
communication [9,14]. The aspiration technique may also lead to a 
more accommodating microenvironment by removing toxic, apoptoic 
cell fragments [5].
In summary, this case series contributes to the literature by 
demonstrating that the defragmentation aspiration technique at the 
blastocyst stage may lead to improved blastocyst expansion, successful 
implantation and ultimately clinical pregnancy. The technique may 
represent a feasible option for improving clinical pregnancy and live 
birth rates in IVF/ICSI, particularly for patients with poorer quality 
embryos. Further comparative, prospective studies are necessary to 
evaluate the role of embryo defragmentation in improving pregnancy 
rates in IVF-ET cycles.
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